Evidence for linkage disequilibrium between the alpha 7-nicotinic receptor gene (CHRNA7) locus and schizophrenia in Azorean families - PubMed (original) (raw)
. 2001 Dec 8;105(8):669-74.
doi: 10.1002/ajmg.1549.
M T Pato, C D Torre, H Medeiros, C Carvalho, V S Basile, A Bauer, A Dourado, J Valente, M J Soares, A A Macedo, I Coelho, C P Ferreira, M H Azevedo, F Macciardi, J L Kennedy, C N Pato
Affiliations
- PMID: 11803513
- DOI: 10.1002/ajmg.1549
Evidence for linkage disequilibrium between the alpha 7-nicotinic receptor gene (CHRNA7) locus and schizophrenia in Azorean families
J Xu et al. Am J Med Genet. 2001.
Abstract
Recent studies have suggested that the alpha 7-nicotinic receptor gene (CHRNA7) may play a role in the pathogenesis of schizophrenia. The alpha 7-nicotinic receptor gene (CHRNA7) is involved in P50 auditory sensory gating deficits, and the genomic locus for this gene lies in the chromosome 15q13-14 regions. The human gene is partially duplicated (exons 5-10) with four novel upstream exons. The marker D15S1360 has been shown to be significantly linked with the phenotype of abnormal P50 suppression in schizophrenia families. The marker L76630 is 3 kb in the 3' direction from the last exon of the CHRNA7 gene and is located in the duplicated region. The function of the two L76630 copies is unknown. We genotyped three polymorphic markers D15S1360, D15S165, and L76630 that are localized in a genomic fragment containing the CHRNA7 in 31 Azorean schizophrenia families/trios (including 41 schizophrenia individuals and 97 unaffected families members). An overall analysis utilizing the family-based association test revealed significant linkage disequilibrium between L76630 and schizophrenia (P = 0.0004). Using the extended transmission disequilibrium test and limiting the analysis to one triad per family, transmission disequilibrium of D15S1360 was near significance (P = 0.078). The 15q13 region overlaps with the location of two well-known genomically imprinted disorders: Angelman syndrome and Prader-Willi syndrome. Therefore, we investigated maternal and paternal meioses. We found significant transmission disequilibrium for D15S1360 through paternal transmission (P = 0.0006) in our schizophrenia families. The L76630 marker showed a significant disequilibrium in maternal transmissions (P = 0.028). No parent-of-origin effect was found in D15S165. Overall, our results suggest that the CHRNA7 may play a role in schizophrenia in these families. A parent of origin effect may be present and requires further study.
Comment in
- Genetic linkage to schizophrenia at chromosome 15q14.
Freedman R, Leonard S. Freedman R, et al. Am J Med Genet. 2001 Dec 8;105(8):655-7. doi: 10.1002/ajmg.1548. Am J Med Genet. 2001. PMID: 11803510 No abstract available.
Similar articles
- Linkage disequilibrium for schizophrenia at the chromosome 15q13-14 locus of the alpha7-nicotinic acetylcholine receptor subunit gene (CHRNA7).
Freedman R, Leonard S, Gault JM, Hopkins J, Cloninger CR, Kaufmann CA, Tsuang MT, Farone SV, Malaspina D, Svrakic DM, Sanders A, Gejman P. Freedman R, et al. Am J Med Genet. 2001 Jan 8;105(1):20-2. Am J Med Genet. 2001. PMID: 11424985 - No association between CHRNA7 microsatellite markers and attention-deficit hyperactivity disorder.
Kent L, Green E, Holmes J, Thapar A, Gill M, Hawi Z, Fitzgerald M, Asherson P, Curran S, Mills J, Payton A, Craddock N. Kent L, et al. Am J Med Genet. 2001 Dec 8;105(8):686-9. doi: 10.1002/ajmg.1553. Am J Med Genet. 2001. PMID: 11803515 - Haplotype transmission disequilibrium and evidence for linkage of the CHRNA7 gene region to schizophrenia in Southern African Bantu families.
Riley BP, Makoff A, Mogudi-Carter M, Jenkins T, Williamson R, Collier D, Murray R. Riley BP, et al. Am J Med Genet. 2000 Apr 3;96(2):196-201. doi: 10.1002/(sici)1096-8628(20000403)96:2<196::aid-ajmg15>3.0.co;2-4. Am J Med Genet. 2000. PMID: 10893497 - Genetics of chromosome 15q13-q14 in schizophrenia.
Leonard S, Freedman R. Leonard S, et al. Biol Psychiatry. 2006 Jul 15;60(2):115-22. doi: 10.1016/j.biopsych.2006.03.054. Biol Psychiatry. 2006. PMID: 16843094 Review. - The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function.
Sinkus ML, Graw S, Freedman R, Ross RG, Lester HA, Leonard S. Sinkus ML, et al. Neuropharmacology. 2015 Sep;96(Pt B):274-88. doi: 10.1016/j.neuropharm.2015.02.006. Epub 2015 Feb 19. Neuropharmacology. 2015. PMID: 25701707 Free PMC article. Review.
Cited by
- Targeted Treatment of Individuals With Psychosis Carrying a Copy Number Variant Containing a Genomic Triplication of the Glycine Decarboxylase Gene.
Bodkin JA, Coleman MJ, Godfrey LJ, Carvalho CMB, Morgan CJ, Suckow RF, Anderson T, Öngür D, Kaufman MJ, Lewandowski KE, Siegel AJ, Waldstreicher E, Grochowski CM, Javitt DC, Rujescu D, Hebbring S, Weinshilboum R, Rodriguez SB, Kirchhoff C, Visscher T, Vuckovic A, Fialkowski A, McCarthy S, Malhotra D, Sebat J, Goff DC, Hudson JI, Lupski JR, Coyle JT, Rudolph U, Levy DL. Bodkin JA, et al. Biol Psychiatry. 2019 Oct 1;86(7):523-535. doi: 10.1016/j.biopsych.2019.04.031. Epub 2019 May 9. Biol Psychiatry. 2019. PMID: 31279534 Free PMC article. Clinical Trial. - Alpha7 Nicotinic Receptors as Therapeutic Targets in Schizophrenia.
Tregellas JR, Wylie KP. Tregellas JR, et al. Nicotine Tob Res. 2019 Feb 18;21(3):349-356. doi: 10.1093/ntr/nty034. Nicotine Tob Res. 2019. PMID: 30137618 Free PMC article. Review. - Homology Modeling and Protein Interaction Map of CHRNA7 Neurogenesis Protein.
Yadav R, Deepshikha D, Srivastava P. Yadav R, et al. Ann Neurosci. 2017 Jul;24(3):173-179. doi: 10.1159/000477155. Epub 2017 Jul 24. Ann Neurosci. 2017. PMID: 28867899 Free PMC article. - Copy number changes and methylation patterns in an isodicentric and a ring chromosome of 15q11-q13: report of two cases and review of literature.
Wang Q, Wu W, Xu Z, Luo F, Zhou Q, Li P, Xie J. Wang Q, et al. Mol Cytogenet. 2015 Dec 21;8:97. doi: 10.1186/s13039-015-0198-4. eCollection 2015. Mol Cytogenet. 2015. PMID: 26697114 Free PMC article. - α7 nicotinic ACh receptor-deficient mice exhibit sustained attention impairments that are reversed by β2 nicotinic ACh receptor activation.
Kolisnyk B, Al-Onaizi MA, Prado VF, Prado MA. Kolisnyk B, et al. Br J Pharmacol. 2015 Oct;172(20):4919-31. doi: 10.1111/bph.13260. Epub 2015 Sep 22. Br J Pharmacol. 2015. PMID: 26222090 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials